Regeneron
Manufacturing · New York, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
777 Old Saw Mill River Rd, Tarrytown, Ne...Phone Number
(914) 847-7000Website
www.regeneron.comRevenue
$14.9 BillionStock Symbol
REGNIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
28
20
1
3
3
3
About Regeneron
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.Explore more
Regeneron Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Regeneron your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Regeneron recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Regeneron
Check if Regeneron has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Regeneron has new funding data
Check out if Regeneron is spiking on competitors!
Click to see if Regeneron had a recent Job posting/layoffs
Regeneron, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Regeneron launches new products
Recommended Actions
Find VP level buyers at Regeneron
Find 2 more new buyers
Compare Similar Companies to Regeneron
Compare insights from companies similar to Regeneron, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Regeneron is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Regeneron is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Regeneron.
Regeneron financials insights
Gather financial insights about Regeneron, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1991
Stock Offering
$91.4M
2010
Stock Offering
$174.7M
2011
Debt
$400M
Regeneron Tech Stack
A closer look at the technologies used by Regeneron
Most Recent Scoops
Hiring Plans
Regeneron has more open roles in Legal than it has had at any time in the past 12 months. Areas of expertise include: Regulatory Affairs, Compliance Implementation, and Regulatory Process.
Hiring Plans
Hiring Plans
Regeneron has more open roles in Marketing than it has had at any time in the past 12 months. Technologies mentioned include: Veeva Vault CRM with an increased focus that include Brand Strategy, Content Strategy, Brand Strategy, and Content Strategy, and experience with Oncology Sales, Pharmaceutical Marketing, and Pharmaceutical Marketing.
Hiring Plans
Hiring Plans
Regeneron has more open roles in Information Technology than it has had at any time in the past 12 months. Technologies mentioned include: Oracle Business Intelligence, Python, cyber security, SoftMax Pro, GitLab, Informatica, and Oracle Cloud Infrastructure. Areas of expertise include: Database Systems, Cloud Design, Data Validation, Google Latitude, Automation, IT Infrastructure, and Infrastructure as Code (IaC).
Hiring Plans
Person-Based
Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Regeneron News & Media
Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
Inmazeb® (a three-antibody cocktail consisting of maftivimab, atoltivimab and odesivimab-ebgn) was the first Ebola treatment approved by the U.S. Food and Drug Administration, indicated specifically for the Orthoebolavirus zairense species, and has been administered to hundreds of patientsCanaccord Cuts PT on Regeneron Pharmaceuticals (REGN), Cites a Disappointing Event
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best medical stocks to invest in according to billionaires. Canaccord cut the price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $875 from $1,057 on May 19, maintaining a Buy rating on the shares. The firm updated its model on the stock after its Phase 3 study of fianlimab+cemiplimab vs […]Are Wall Street Analysts Predicting Regeneron Pharmaceuticals Stock Will Climb or Sink?
Regeneron Pharmaceuticals has underperformed the broader market over the past year, and analysts remain reasonably bullish about the stock’s long term prospects.Regeneron (REGN) Enters $2.32B Collaboration With Parabilis to Target ‘Undruggable’ Proteins
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the cheap NASDAQ stocks to buy right now. On May 19, Regeneron Pharmaceuticals entered into a $2.32 billion research collaboration with Parabilis Medicines to develop therapeutic candidates using Parabilis’ Helicon peptide platform. The partnership will focus on creating Helicons (stabilized, cell-penetrant alpha-helical peptides) that can be used as […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Regeneron
Sign Up For FreeTo access detailed company insights
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.... Read More
